Quest Diagnostics
DGX
#960
Rank
โ‚น2.452 T
Marketcap
โ‚น22,224
Share price
-0.55%
Change (1 day)
52.22%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2026 (TTM): โ‚น122.90 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น11.27 Billion. In 2025 the company made an earning of โ‚น125.71 Billion, an increase over its 2024 earnings that were of โ‚น112.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น122.90 B-2.23%
2025 โ‚น125.71 B12.17%
2024 โ‚น112.07 B3.98%
2023 โ‚น107.77 B-8.5%
2022 โ‚น117.79 B-52.48%
2021 โ‚น247.89 B37.95%
2020 โ‚น179.69 B75.09%
2019 โ‚น102.62 B16.2%
2018 โ‚น88.32 B-10.1%
2017 โ‚น98.24 B-5.16%
2016 โ‚น103.58 B-1.54%
2015 โ‚น105.20 B31%
2014 โ‚น80.30 B-37.52%
2013 โ‚น128.54 B26.93%
2012 โ‚น101.27 B24.01%
2011 โ‚น81.66 B-27.7%
2010 โ‚น112.96 B-3.55%
2009 โ‚น117.12 B19.59%
2008 โ‚น97.93 B12.54%
2007 โ‚น87.02 B-11.7%
2006 โ‚น98.55 B13.49%
2005 โ‚น86.83 B9.02%
2004 โ‚น79.65 B13.19%
2003 โ‚น70.37 B36.03%
2002 โ‚น51.73 B63.07%
2001 โ‚น31.72 B65.49%
2000 โ‚น19.16 B1297.84%
1999 โ‚น1.37 B-73.37%
1998 โ‚น5.15 B-384.21%
1997 -โ‚น1.82 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
โ‚น131.16 B-0.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.97 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น0.19 Billion-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.49 Billion-107.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น47.07 B-64.13%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น0.75 Billion-100.57%๐Ÿ‡บ๐Ÿ‡ธ USA